In 21st centuary, cellular and gene therapies are becoming increasingly dominant treatment methods. In this context, Celgentera, Biomedical, Pharmaceutical and Health Services Ltd., is poised to become a leading company in Turkey, providing a variety of consumables, devices, and services as a supply chain for cellular and gene therapies
To supply the best consumables and devices or instruments to our customers for cell therapy or gene therapies